The impact of Human Epidermal growth factor Receptor 2 (HER2) expression by RT-PCR on tumor characteristics and outcome in estrogen receptor (ER) positive, HER2 negative early-stage breast cancer

被引：0
|
作者：
Goldvaser, Hadar
Mutai, Raz
Stemmer, Salomon
Kuchuk, Iryna
Tokar, Margarita
Paluch-Shimon, Shani
Yerushalmi, Rinat
Drumea, Karen
Evron, Ella
Sonnenblick, Amir
Gal-Yam, Einav
Bar Sela, Gil
Shai, Ayelet
Merose, Rotem
Bareket-Samish, Avital
Soussan-Gutman, Lior
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-01-08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-01-08
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Dual targeting of human epidermal growth factor receptor 2 (HER2) in neoadjuvant trials for operable HER2 positive (HER2+) disease
    Jhaveri K.
    Dang C.
    Current Breast Cancer Reports, 2013, 5 (4) : 321 - 330
  • [22] Gene Expression and miRNAs Profiling: Function and Regulation in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
    Sareyeldin, Rasha M.
    Gupta, Ishita
    Al-Hashimi, Israa
    Al-Thawadi, Hamda A.
    Al Farsi, Halema E.
    Vranic, Semir
    Al Moustafa, Ala-Eddin
    CANCERS, 2019, 11 (05)
  • [23] Coregulation of epidermal growth factor receptor/human epidermal growth factor receptor 2 (HER2) levels and locations: Quantitative analysis of HER2 overexpression effects
    Hendriks, BS
    Opresko, LK
    Wiley, HS
    Lauffenburger, D
    CANCER RESEARCH, 2003, 63 (05) : 1130 - 1137
  • [24] COMPARISON OF HER2 mRNA PCR LEVELS AND IMMUNOHISTOCHEMISTRY (IHC) IN HORMONE RECEPTOR POSITIVE (HR+)/HER2 NEGATIVE (HER2-) EARLY BREAST CANCER
    Tejerina-Peces, Julia
    Amann-Arevalo, Marta
    Ballestin, Pablo
    Gonzalez-Diez, Beatriz
    Paz-Cabezas, Mateo
    Pascual, Alejandro
    de Luna, Alicia
    Garcia-Barberan, Vanesa
    Lopez de Sa, Alfonso
    Garcia-Saenz, Jose Angel
    Moreno, Fernando
    CANCER RESEARCH, 2024, 84 (09)
  • [25] HER2 Activating Mutations in Estrogen Receptor Positive Breast Cancer
    Murray E.M.
    Cherian M.A.
    Ma C.X.
    Bose R.
    Current Breast Cancer Reports, 2018, 10 (2) : 41 - 47
  • [26] Targeting the Human Epidermal Growth Factor Receptor Family in Breast Cancer beyond HER2
    Riecke, Kerstin
    Witzel, Isabell
    BREAST CARE, 2020, 15 (06) : 579 - 585
  • [27] Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
    Alves, Fatima R.
    Gil, Lucia
    de Matos, Leonor Vasconcelos
    Baleiras, Ana
    Vasques, Carolina
    Neves, Maria Teresa
    Ferreira, Andre
    Fontes-Sousa, Mario
    Miranda, Helena
    Martins, Ana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [28] Human epidermal growth factor receptor 2 (HER2) expression in urothelial carcinomas of the bladder
    Nalwa, A.
    Elhence, A. B. S. P.
    Bharti, J. Naresh
    Rao, M.
    Choudhary, G. Ram
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S170 - S171
  • [29] Targeting Rac/Cdc42 in human epidermal growth factor receptor 2 (HER2)-positive breast cancer
    Rivera-Robles, M. J.
    Medina-Vlazquez, J. I.
    Borrero-Garcia, L. D.
    Velazquez-Vega, L. E.
    Maldonado, Md M.
    Ruiz-Calderon, J.
    Castillo-Pichardo, L.
    Vivas-Mejia, P.
    Dharmawardhane, S.
    CANCER RESEARCH, 2019, 79 (04)
  • [30] HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
    Batra, Atul
    Kumar, Akash
    BREAST, 2021, 55 : 136 - 136
12345